Finance

Lists
NL0:FRA
Grail Inc
€57.66
-1.17%
(-0.68) 1D
Aug 14, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NL0...
Open
€57.66
High
€57.66
Low
€57.66
Mkt. cap
3.03B
Avg. vol.
86.00
Volume
0.00
52-wk high
€97.80
52-wk low
€26.70
No. of employees
910
Open
€57.66
High
€57.66
Low
€57.66
Mkt. cap
3.03B
Avg. vol.
86.00
Volume
0.00
52-wk high
€97.80
52-wk low
€26.70
No. of employees
910
News stories
From web sources and news partners
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
36.19M
43.60M
40.78M
44.69M
Cost of goods sold
16.45M
21.26M
21.62M
23.78M
Cost of revenue
16.45M
21.26M
21.62M
23.78M
Research and development expenses
48.65M
46.90M
48.02M
47.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.91M
66.38M
73.44M
88.36M
Operating expense
145.03M
146.75M
154.93M
169.27M
Total operating expenses
161.48M
168.01M
176.55M
193.05M
Operating income
-125.29M
-124.41M
-135.76M
-148.36M
Other non operating income
-
-993.00K
-
-
EBT including unusual items
-118.72M
-116.52M
-127.52M
-166.71M
EBT excluding unusual items
-118.72M
-116.52M
-127.52M
-141.28M
Income tax expense
-29.74M
-17.34M
-34.34M
-56.46M
Effective tax rate
25.05%
14.88%
26.93%
33.87%
Other operating expenses
-
-
-
-
Net income
-88.98M
-99.18M
-93.19M
-110.25M
Net profit margin
-245.83%
-227.48%
-228.48%
-246.71%
Earnings per share
-2.46
-2.44
-1.37
-1.34
Interest and investment income
6.11M
7.96M
7.99M
7.23M
Interest expense
-
-
-
-
Net interest expenses
6.11M
7.96M
7.99M
7.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
-86.31M
-85.50M
-96.97M
-109.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps